Header Logo

Connection

ARGUN AKCAKANAT to Cyclophosphamide

Back to Details
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Cyclophosphamide.
ARGUN AKCAKANAT
Connection Strength
0.017
Cyclophosphamide
  1. Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer?. Ann Oncol. 2014 Jun; 25(6):1122-7.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.